ORPH Gains 302.3%

Thu, Jun 10, 2021 at 05:33 PM

ORPH (ORPH:NASDAQ) rocketted at $21, a gain of 302.3%. The stock appeared on our News Catalysts scanner on Thu, Jun 10, 2021 at 04:50 PM in the 'HALT' category. From Wed, May 26, 2021, the stock recorded 55.56% Up Days and 30.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About ORPH (ORPH:NASDAQ)

Orphazyme A/S is a Danish biotech company. It is engaged in the development of paradigm-changing medicines for the treatment of protein misfolding diseases.

Top 10 Gainers:

ORPH (ORPH:NASDAQ), 302.3%
Trxade Group, Inc. (MEDS:NASDAQ), 63.48%
Sphere 3D Corp. (ANY:NASDAQ), 60.5%
GLTO (GLTO:NASDAQ), 60%
Axcella Health Inc. (AXLA:NASDAQ), 48.7%
Heat Biologics, Inc. (HTBX:NASDAQ), 40.15%
Medley Management Inc. (MDLY:NYSE), 36.64%
Yiren Digital Ltd. (YRD:NYSE), 29.44%
DBGI (DBGI:NASDAQ), 27.3%
AMST (AMST:NASDAQ), 25.34%